BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 30006355)

  • 21. Novel suprasellar location of desmoplastic infantile astrocytoma and ganglioglioma: a single institution's experience.
    Naylor RM; Wohl A; Raghunathan A; Eckel LJ; Keating GF; Daniels DJ
    J Neurosurg Pediatr; 2018 Oct; 22(4):397-403. PubMed ID: 29979130
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genomic and epigenomic re-categorization of congenital glioblastoma and desmoplastic infantile ganglioglioma.
    Gilani A; Siddiq Z; Kissell E; Kasson J; Kleinschmidt-DeMasters BK
    Childs Nerv Syst; 2023 Jul; 39(7):1861-1868. PubMed ID: 36707425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The molecular characteristics of low-grade and high-grade areas in desmoplastic infantile astrocytoma/ganglioglioma.
    Chiang J; Li X; Jin H; Wu G; Lin T; Ellison DW
    Neuropathol Appl Neurobiol; 2022 Jun; 48(4):e12801. PubMed ID: 35191090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integrated genotype-phenotype analysis of long-term epilepsy-associated ganglioglioma.
    Wang Y; Wang L; Blümcke I; Zhang W; Fu Y; Shan Y; Piao Y; Zhao G
    Brain Pathol; 2022 Jan; 32(1):e13011. PubMed ID: 34355449
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Desmoplastic infantile astrocytoma and ganglioglioma: a search for genomic characteristics.
    Kros JM; Delwel EJ; de Jong TH; Tanghe HL; van Run PR; Vissers K; Alers JC
    Acta Neuropathol; 2002 Aug; 104(2):144-8. PubMed ID: 12111357
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel BRAF alteration in desmoplastic infantile ganglioglioma with response to targeted therapy.
    Blessing MM; Blackburn PR; Balcom JR; Krishnan C; Harrod VL; Zimmermann MT; Barr Fritcher EG; Zysk CD; Jackson RA; Nair AA; Jenkins RB; Halling KC; Kipp BR; Ida CM
    Acta Neuropathol Commun; 2018 Nov; 6(1):118. PubMed ID: 30396366
    [No Abstract]   [Full Text] [Related]  

  • 27. Detection of BRAF V600E Mutation in Ganglioglioma and Pilocytic Astrocytoma by Immunohistochemistry and Real-Time PCR-Based Idylla Test.
    Durślewicz J; Klimaszewska-Wiśniewska A; Antosik P; Kasperska A; Grzanka D; Szylberg T; Szylberg Ł
    Dis Markers; 2020; 2020():8880548. PubMed ID: 32879641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Desmoplastic infantile ganglioglioma/astrocytoma with cerebrospinal metastasis.
    Darwish B; Arbuckle S; Kellie S; Besser M; Chaseling R
    J Clin Neurosci; 2007 May; 14(5):498-501. PubMed ID: 17386372
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Co-occurrence of histone H3 K27M and BRAF V600E mutations in paediatric midline grade I ganglioglioma.
    Pagès M; Beccaria K; Boddaert N; Saffroy R; Besnard A; Castel D; Fina F; Barets D; Barret E; Lacroix L; Bielle F; Andreiuolo F; Tauziède-Espariat A; Figarella-Branger D; Puget S; Grill J; Chrétien F; Varlet P
    Brain Pathol; 2018 Jan; 28(1):103-111. PubMed ID: 27984673
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Response in a child with a BRAF V600E mutated desmoplastic infantile astrocytoma upon retreatment with vemurafenib.
    van Tilburg CM; Selt F; Sahm F; Bächli H; Pfister SM; Witt O; Milde T
    Pediatr Blood Cancer; 2018 Mar; 65(3):. PubMed ID: 29230924
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BRAF V600E mutations are frequent in dysembryoplastic neuroepithelial tumors and subependymal giant cell astrocytomas.
    Lee D; Cho YH; Kang SY; Yoon N; Sung CO; Suh YL
    J Surg Oncol; 2015 Mar; 111(3):359-64. PubMed ID: 25346165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low-grade developmental and epilepsy associated brain tumors: a critical update 2020.
    Slegers RJ; Blumcke I
    Acta Neuropathol Commun; 2020 Mar; 8(1):27. PubMed ID: 32151273
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphology.
    Qaddoumi I; Orisme W; Wen J; Santiago T; Gupta K; Dalton JD; Tang B; Haupfear K; Punchihewa C; Easton J; Mulder H; Boggs K; Shao Y; Rusch M; Becksfort J; Gupta P; Wang S; Lee RP; Brat D; Peter Collins V; Dahiya S; George D; Konomos W; Kurian KM; McFadden K; Serafini LN; Nickols H; Perry A; Shurtleff S; Gajjar A; Boop FA; Klimo PD; Mardis ER; Wilson RK; Baker SJ; Zhang J; Wu G; Downing JR; Tatevossian RG; Ellison DW
    Acta Neuropathol; 2016 Jun; 131(6):833-45. PubMed ID: 26810070
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ganglioglioma with anaplastic/high-grade transformation: Histopathologic, molecular, and epigenetic characterization of 3 cases.
    Vizcaino MA; Giannini C; Lalich D; Nael A; Jenkins RB; Tran Q; Orr BA; Abdullaev Z; Aldape K; Vaubel RA
    J Neuropathol Exp Neurol; 2024 May; 83(6):416-424. PubMed ID: 38699943
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical relevance of BRAF status in glial and glioneuronal tumors: A systematic review.
    Sugiura Y; Nagaishi M
    J Clin Neurosci; 2019 Aug; 66():196-201. PubMed ID: 31147232
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined "Infiltrating Astrocytoma/Pleomorphic Xanthoastrocytoma" Harboring IDH1 R132H and BRAF V600E Mutations.
    Yamada S; Kipp BR; Voss JS; Giannini C; Raghunathan A
    Am J Surg Pathol; 2016 Feb; 40(2):279-84. PubMed ID: 26414224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-grade desmoplastic infantile astrocytoma in a 1-year-old child with Down's syndrome: a case report.
    Habib MH; Alavi MZ; Goraya A; Zaman S; Ahmed A
    J Med Case Rep; 2022 Nov; 16(1):427. PubMed ID: 36333774
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The differential diagnosis of pilocytic astrocytoma with atypical features and malignant glioma: an analysis of 16 cases with emphasis on distinguishing molecular features.
    Cykowski MD; Allen RA; Kanaly AC; Fung KM; Marshall R; Perry A; Stolzenberg ED; Dunn ST
    J Neurooncol; 2013 Dec; 115(3):477-86. PubMed ID: 24057326
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of BRAFV600 in glioma and use of BRAF Inhibitors in patients with BRAFV600 mutation-positive glioma: systematic review.
    Andrews LJ; Thornton ZA; Saincher SS; Yao IY; Dawson S; McGuinness LA; Jones HE; Jefferies S; Short SC; Cheng HY; McAleenan A; Higgins JPT; Kurian KM
    Neuro Oncol; 2022 Apr; 24(4):528-540. PubMed ID: 34718782
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Desmoplastic infantile astrocytoma: recurrence with malignant transformation into glioblastoma: a case report.
    Phi JH; Koh EJ; Kim SK; Park SH; Cho BK; Wang KC
    Childs Nerv Syst; 2011 Dec; 27(12):2177-81. PubMed ID: 21947035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.